Graphite Bio
(NASDAQ) GRPH
Graphite Bio Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$19.09M
Net Income (TTM)
$82.13M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
GRPH News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Graphite Bio
Industry
Biotechnology
Sector
Health CareEmployees
152
CEO
Evert B. Schimmelpennink
Website
www.lenz-tx.comHeadquarters
South San Francisco, CA 94080, US
GRPH Financials
Key Financial Metrics (TTM)
Gross Margin
97%
Operating Margin
-5%
Net Income Margin
-4%
Return on Equity
-37%
Return on Capital
-32%
Return on Assets
-27%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$18.67M
Operating Income
$91.14M
EBITDA
$91.14M
Operating Cash Flow
$69.17M
Capital Expenditure
$827.00K
Free Cash Flow
$70.00M
Cash & ST Invst.
$292.35M
Total Debt
$350.00K
Graphite Bio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.59M
+115.5%
Gross Profit
$18.67M
+300.9%
Gross Margin
11.76%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
6
N/A
Net Income
$35.90M
-392.3%
EBITDA
$38.46M
-189.0%
Quarterly Fundamentals
Net Cash
$292.00M
+40.2%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$350.00K
-57.0%
Short Term Debt
$0.00
N/A
Return on Assets
-26.85%
N/A
Return on Invested Capital
-32.01%
N/A
Free Cash Flow
$33.06M
-236.5%
Operating Cash Flow
$33.02M
-266.6%